APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetic Research

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmacokinetic Research Market Outlook and Growth Opportunities 2026

3 May 2026199 pages

Choose your research edition.

Industry ResearchPharmacokinetic Research Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetic Research Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmacokinetic Research Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetic Research Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetic Research Market Analysis and Forecast 2026-2032241 pages · $4,950 USD

Market perspective

The global Pharmacokinetic Research market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacokinetic Research is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmacokinetic Research market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmacokinetic Research market include Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences and Allucent, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmacokinetic Research market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacokinetic Research and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacokinetic Research revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacokinetic Research market.

Pharmacokinetic Research Segment by Company

Eurofins

PPD

LabCorp

Charles River

BioPharma Services

Biotrial

QPS Holdings

Altasciences

Allucent

Admescope

CTI

WuXi AppTec

GenScript

Wuxi Biologics

Medicilon

Pharmaron

Frontage

Shanghai Model

Pharmacokinetic Research Segment by Type

In Vitro and Radioactive ADME

In Vivo PK and PD

New Drugs and New Molecules

Other

Pharmacokinetic Research Segment by Application

Pharmaceutical Industry

Government Agencies and Ministry of Health

Agriculture and Chemical Industry

University

Pharmacokinetic Research Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmacokinetic Research status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacokinetic Research key companies, revenue, market share, and recent developments.

3. To split the Pharmacokinetic Research breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacokinetic Research market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacokinetic Research significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacokinetic Research competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Research market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Research and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Research.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetic Research industry.

Chapter 3: Detailed analysis of Pharmacokinetic Research company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacokinetic Research in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacokinetic Research in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacokinetic Research Industry Trends Table 2. Pharmacokinetic Research Industry Drivers Table 3. Pharmacokinetic Research Industry Opportunities and Challenges Table 4. Pharmacokinetic Research Industry Restraints Table 5. Global Pharmacokinetic Research Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacokinetic Research Revenue Share by Company (2021-2026) Table 7. Global Pharmacokinetic Research Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacokinetic Research Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacokinetic Research Company, Product Type & Application Table 10. Global Pharmacokinetic Research Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacokinetic Research by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vitro and Radioactive ADME Table 15. Significant Companies of In Vivo PK and PD Table 16. Significant Companies of New Drugs and New Molecules Table 17. Significant Companies of Other Table 18. Global Pharmacokinetic Research Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmacokinetic Research Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmacokinetic Research Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmacokinetic Research Sales Value Share by Type (2021-2026) Table 22. Global Pharmacokinetic Research Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Industry Table 24. Significant Companies of Government Agencies and Ministry of Health Table 25. Significant Companies of Agriculture and Chemical Industry Table 26. Significant Companies of University Table 27. Global Pharmacokinetic Research Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmacokinetic Research Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pharmacokinetic Research Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pharmacokinetic Research Sales Value Share by Application (2021-2026) Table 31. Global Pharmacokinetic Research Sales Value Share by Application (2027-2032) Table 32. Global Pharmacokinetic Research Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmacokinetic Research Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pharmacokinetic Research Sales Value Share by Region (2021-2026) Table 35. Global Pharmacokinetic Research Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pharmacokinetic Research Sales Value Share by Region (2027-2032) Table 37. Global Pharmacokinetic Research Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmacokinetic Research Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pharmacokinetic Research Sales Value Market Share by Country (2021-2026) Table 40. Global Pharmacokinetic Research Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pharmacokinetic Research Sales Value Market Share by Country (2027-2032) Table 42. Eurofins Company Information Table 43. Eurofins Business Overview Table 44. Eurofins Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Eurofins Pharmacokinetic Research Product Portfolio Table 46. Eurofins Recent Development Table 47. PPD Company Information Table 48. PPD Business Overview Table 49. PPD Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. PPD Pharmacokinetic Research Product Portfolio Table 51. PPD Recent Development Table 52. LabCorp Company Information Table 53. LabCorp Business Overview Table 54. LabCorp Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. LabCorp Pharmacokinetic Research Product Portfolio Table 56. LabCorp Recent Development Table 57. Charles River Company Information Table 58. Charles River Business Overview Table 59. Charles River Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Charles River Pharmacokinetic Research Product Portfolio Table 61. Charles River Recent Development Table 62. BioPharma Services Company Information Table 63. BioPharma Services Business Overview Table 64. BioPharma Services Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. BioPharma Services Pharmacokinetic Research Product Portfolio Table 66. BioPharma Services Recent Development Table 67. Biotrial Company Information Table 68. Biotrial Business Overview Table 69. Biotrial Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Biotrial Pharmacokinetic Research Product Portfolio Table 71. Biotrial Recent Development Table 72. QPS Holdings Company Information Table 73. QPS Holdings Business Overview Table 74. QPS Holdings Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. QPS Holdings Pharmacokinetic Research Product Portfolio Table 76. QPS Holdings Recent Development Table 77. Altasciences Company Information Table 78. Altasciences Business Overview Table 79. Altasciences Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Altasciences Pharmacokinetic Research Product Portfolio Table 81. Altasciences Recent Development Table 82. Allucent Company Information Table 83. Allucent Business Overview Table 84. Allucent Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Allucent Pharmacokinetic Research Product Portfolio Table 86. Allucent Recent Development Table 87. Admescope Company Information Table 88. Admescope Business Overview Table 89. Admescope Pharmacokinetic Research Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Admescope Pharmacokinetic Research Product Portfolio Table 91. Admescope Recent Development Table 92. CTI Company Information Table 93. CTI Business Overview Table 94. CTI Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. CTI Pharmacokinetic Research Product Portfolio Table 96. CTI Recent Development Table 97. WuXi AppTec Company Information Table 98. WuXi AppTec Business Overview Table 99. WuXi AppTec Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. WuXi AppTec Pharmacokinetic Research Product Portfolio Table 101. WuXi AppTec Recent Development Table 102. GenScript Company Information Table 103. GenScript Business Overview Table 104. GenScript Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. GenScript Pharmacokinetic Research Product Portfolio Table 106. GenScript Recent Development Table 107. Wuxi Biologics Company Information Table 108. Wuxi Biologics Business Overview Table 109. Wuxi Biologics Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Wuxi Biologics Pharmacokinetic Research Product Portfolio Table 111. Wuxi Biologics Recent Development Table 112. Medicilon Company Information Table 113. Medicilon Business Overview Table 114. Medicilon Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Medicilon Pharmacokinetic Research Product Portfolio Table 116. Medicilon Recent Development Table 117. Pharmaron Company Information Table 118. Pharmaron Business Overview Table 119. Pharmaron Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Pharmaron Pharmacokinetic Research Product Portfolio Table 121. Pharmaron Recent Development Table 122. Frontage Company Information Table 123. Frontage Business Overview Table 124. Frontage Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Frontage Pharmacokinetic Research Product Portfolio Table 126. Frontage Recent Development Table 127. Shanghai Model Company Information Table 128. Shanghai Model Business Overview Table 129. Shanghai Model Pharmacokinetic Research Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Shanghai Model Pharmacokinetic Research Product Portfolio Table 131. Shanghai Model Recent Development Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Pharmacokinetic Research Product Image Figure 2. Global Pharmacokinetic Research Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacokinetic Research Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacokinetic Research Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vitro and Radioactive ADME Image Figure 8. In Vivo PK and PD Image Figure 9. New Drugs and New Molecules Image Figure 10. Other Image Figure 11. Global Pharmacokinetic Research Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmacokinetic Research Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmacokinetic Research Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Industry Image Figure 15. Government Agencies and Ministry of Health Image Figure 16. Agriculture and Chemical Industry Image Figure 17. University Image Figure 18. Global Pharmacokinetic Research Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmacokinetic Research Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmacokinetic Research Sales Value Share by Application (2021-2032) Figure 21. Global Pharmacokinetic Research Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pharmacokinetic Research Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pharmacokinetic Research Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pharmacokinetic Research Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pharmacokinetic Research Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pharmacokinetic Research Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pharmacokinetic Research Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pharmacokinetic Research Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pharmacokinetic Research Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pharmacokinetic Research Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pharmacokinetic Research Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pharmacokinetic Research Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pharmacokinetic Research Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro and Radioactive ADME
  • In Vivo PK and PD
  • New Drugs and New Molecules
  • Other
Applications
  • Pharmaceutical Industry
  • Government Agencies and Ministry of Health
  • Agriculture and Chemical Industry
  • University
Companies covered
  • Eurofins
  • PPD
  • LabCorp
  • Charles River
  • BioPharma Services
  • Biotrial
  • QPS Holdings
  • Altasciences
  • Allucent
  • Admescope
  • CTI
  • WuXi AppTec
  • GenScript
  • Wuxi Biologics
  • Medicilon
  • Pharmaron
  • Frontage
  • Shanghai Model

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacokinetic Research Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacokinetic Research Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacokinetic Research Market Dynamics
  1. 2.1 Pharmacokinetic Research Industry Trends
  2. 2.2 Pharmacokinetic Research Industry Drivers
  3. 2.3 Pharmacokinetic Research Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetic Research Industry Restraints
3 Pharmacokinetic Research Market by Company
  1. 3.1 Global Pharmacokinetic Research Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacokinetic Research Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacokinetic Research Company Ranking (2024-2026)
  4. 3.4 Global Pharmacokinetic Research Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacokinetic Research Company Product Type and Application
  6. 3.6 Global Pharmacokinetic Research Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacokinetic Research Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacokinetic Research Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacokinetic Research Market by Type
  1. 4.1 Pharmacokinetic Research Type Introduction
  2. 4.1.1 In Vitro and Radioactive ADME
  3. 4.1.2 In Vivo PK and PD
  4. 4.1.3 New Drugs and New Molecules
  5. 4.1.4 Other
  6. 4.2 Global Pharmacokinetic Research Sales Value by Type
  7. 4.2.1 Global Pharmacokinetic Research Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmacokinetic Research Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmacokinetic Research Sales Value Share by Type (2021-2032)
5 Pharmacokinetic Research Market by Application
  1. 5.1 Pharmacokinetic Research Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Government Agencies and Ministry of Health
  4. 5.1.3 Agriculture and Chemical Industry
  5. 5.1.4 University
  6. 5.2 Global Pharmacokinetic Research Sales Value by Application
  7. 5.2.1 Global Pharmacokinetic Research Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmacokinetic Research Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pharmacokinetic Research Sales Value Share by Application (2021-2032)
6 Pharmacokinetic Research Regional Value Analysis
  1. 6.1 Global Pharmacokinetic Research Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacokinetic Research Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacokinetic Research Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacokinetic Research Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacokinetic Research Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacokinetic Research Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacokinetic Research Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacokinetic Research Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacokinetic Research Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacokinetic Research Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacokinetic Research Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacokinetic Research Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacokinetic Research Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacokinetic Research Sales Value Share by Country, 2025 VS 2032
7 Pharmacokinetic Research Country-level Value Analysis
  1. 7.1 Global Pharmacokinetic Research Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacokinetic Research Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacokinetic Research Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacokinetic Research Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacokinetic Research Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacokinetic Research Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacokinetic Research Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins
  2. 8.1.1 Eurofins Company Information
  3. 8.1.2 Eurofins Business Overview
  4. 8.1.3 Eurofins Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Pharmacokinetic Research Product Portfolio
  6. 8.1.5 Eurofins Recent Developments
  7. 8.2 PPD
  8. 8.2.1 PPD Company Information
  9. 8.2.2 PPD Business Overview
  10. 8.2.3 PPD Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PPD Pharmacokinetic Research Product Portfolio
  12. 8.2.5 PPD Recent Developments
  13. 8.3 LabCorp
  14. 8.3.1 LabCorp Company Information
  15. 8.3.2 LabCorp Business Overview
  16. 8.3.3 LabCorp Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LabCorp Pharmacokinetic Research Product Portfolio
  18. 8.3.5 LabCorp Recent Developments
  19. 8.4 Charles River
  20. 8.4.1 Charles River Company Information
  21. 8.4.2 Charles River Business Overview
  22. 8.4.3 Charles River Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Pharmacokinetic Research Product Portfolio
  24. 8.4.5 Charles River Recent Developments
  25. 8.5 BioPharma Services
  26. 8.5.1 BioPharma Services Company Information
  27. 8.5.2 BioPharma Services Business Overview
  28. 8.5.3 BioPharma Services Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioPharma Services Pharmacokinetic Research Product Portfolio
  30. 8.5.5 BioPharma Services Recent Developments
  31. 8.6 Biotrial
  32. 8.6.1 Biotrial Company Information
  33. 8.6.2 Biotrial Business Overview
  34. 8.6.3 Biotrial Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biotrial Pharmacokinetic Research Product Portfolio
  36. 8.6.5 Biotrial Recent Developments
  37. 8.7 QPS Holdings
  38. 8.7.1 QPS Holdings Company Information
  39. 8.7.2 QPS Holdings Business Overview
  40. 8.7.3 QPS Holdings Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QPS Holdings Pharmacokinetic Research Product Portfolio
  42. 8.7.5 QPS Holdings Recent Developments
  43. 8.8 Altasciences
  44. 8.8.1 Altasciences Company Information
  45. 8.8.2 Altasciences Business Overview
  46. 8.8.3 Altasciences Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Altasciences Pharmacokinetic Research Product Portfolio
  48. 8.8.5 Altasciences Recent Developments
  49. 8.9 Allucent
  50. 8.9.1 Allucent Company Information
  51. 8.9.2 Allucent Business Overview
  52. 8.9.3 Allucent Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Allucent Pharmacokinetic Research Product Portfolio
  54. 8.9.5 Allucent Recent Developments
  55. 8.10 Admescope
  56. 8.10.1 Admescope Company Information
  57. 8.10.2 Admescope Business Overview
  58. 8.10.3 Admescope Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Admescope Pharmacokinetic Research Product Portfolio
  60. 8.10.5 Admescope Recent Developments
  61. 8.11 CTI
  62. 8.11.1 CTI Company Information
  63. 8.11.2 CTI Business Overview
  64. 8.11.3 CTI Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CTI Pharmacokinetic Research Product Portfolio
  66. 8.11.5 CTI Recent Developments
  67. 8.12 WuXi AppTec
  68. 8.12.1 WuXi AppTec Company Information
  69. 8.12.2 WuXi AppTec Business Overview
  70. 8.12.3 WuXi AppTec Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  71. 8.12.4 WuXi AppTec Pharmacokinetic Research Product Portfolio
  72. 8.12.5 WuXi AppTec Recent Developments
  73. 8.13 GenScript
  74. 8.13.1 GenScript Company Information
  75. 8.13.2 GenScript Business Overview
  76. 8.13.3 GenScript Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  77. 8.13.4 GenScript Pharmacokinetic Research Product Portfolio
  78. 8.13.5 GenScript Recent Developments
  79. 8.14 Wuxi Biologics
  80. 8.14.1 Wuxi Biologics Company Information
  81. 8.14.2 Wuxi Biologics Business Overview
  82. 8.14.3 Wuxi Biologics Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Wuxi Biologics Pharmacokinetic Research Product Portfolio
  84. 8.14.5 Wuxi Biologics Recent Developments
  85. 8.15 Medicilon
  86. 8.15.1 Medicilon Company Information
  87. 8.15.2 Medicilon Business Overview
  88. 8.15.3 Medicilon Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Medicilon Pharmacokinetic Research Product Portfolio
  90. 8.15.5 Medicilon Recent Developments
  91. 8.16 Pharmaron
  92. 8.16.1 Pharmaron Company Information
  93. 8.16.2 Pharmaron Business Overview
  94. 8.16.3 Pharmaron Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Pharmaron Pharmacokinetic Research Product Portfolio
  96. 8.16.5 Pharmaron Recent Developments
  97. 8.17 Frontage
  98. 8.17.1 Frontage Company Information
  99. 8.17.2 Frontage Business Overview
  100. 8.17.3 Frontage Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Frontage Pharmacokinetic Research Product Portfolio
  102. 8.17.5 Frontage Recent Developments
  103. 8.18 Shanghai Model
  104. 8.18.1 Shanghai Model Company Information
  105. 8.18.2 Shanghai Model Business Overview
  106. 8.18.3 Shanghai Model Pharmacokinetic Research Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shanghai Model Pharmacokinetic Research Product Portfolio
  108. 8.18.5 Shanghai Model Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst